The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure

This study reports preclinical data showing that the interleukin (IL)-1β modulation is a new promising target in the pathophysiological context of heart failure. Indeed, in nondiabetic Wistar and diabetic Goto-Kakizaki rats with chronic heart failure induced by myocardial infarction, administration...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JACC Basic Transl Sci
Autori principali: Harouki, Najah, Nicol, Lionel, Remy-Jouet, Isabelle, Henry, Jean-Paul, Dumesnil, Anais, Lejeune, Annie, Renet, Sylvanie, Golding, Francesca, Djerada, Zoubir, Wecker, Didier, Bolduc, Virginie, Bouly, Muriel, Roussel, Jerome, Richard, Vincent, Mulder, Paul
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2017
Soggetti:
MINI-FOCUS: INFLAMMATION IN CARDIAC INJURY
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6034492/
https://ncbi.nlm.nih.gov/pubmed/30062160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2017.06.005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi